ESR1 and invasive breast carcinoma: To define the co-expression relationship between SEMA3C and the estrogen receptor, we used mRNA expression data of SEMA3C and ESR1 from a TCGA study (Firehose Legacy-Breast Invasive Carcinoma) with 1100 samples [22].